The University of Chicago Header Logo

Key questions regarding the SYMPLICITY HTN-3 trial - Authors' reply.

Key questions regarding the SYMPLICITY HTN-3 trial - Authors' reply. Lancet. 2023 04 22; 401(10385):1337-1338.

View in: PubMed